Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02967185
Other study ID # 221286
Secondary ID
Status Completed
Phase Phase 2
First received November 8, 2016
Last updated November 15, 2016
Start date May 2005
Est. completion date April 2008

Study information

Verified date November 2016
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The proposed study will examine changes in older insomniacs' cognitive functioning following behavioral treatment for insomnia using a combination of two methods. A traditional repeated measures design will be used to look at group level differences based on performance on a neuropsychological battery administered prior to, immediately after, and 3 months after completing a 4 week behavioral treatment program for insomnia. This data will be analyzed using standard repeated measures analytic techniques. A time-series design will also be used to look at within-subject differences based on a brief cognitive battery that will be self-administered on a daily basis. Data from this daily battery will be examined using intraindividual variability modeling.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date April 2008
Est. primary completion date April 2008
Accepts healthy volunteers No
Gender Both
Age group 65 Years and older
Eligibility Inclusion Criteria:

- Age >65 years

- Community dwelling

- Available for duration of study

- Insomnia according to American Sleep Disorders Association (1990) criteria: (a) >30 minutes of unwanted awake time, 3 nights per week for at least 6 months and (b) Daytime dysfunction (reported mood, cognitive, social, or occupational impairment)

Exclusion Criteria:

- Age less than 65

- history of primary sleep disorder (e.g., sleep apnea, narcolepsy)

- history of stroke

- major medical illness known to contribute to sleep problems in last 12 months

- cognitive impairment that interferes with ability to understand treatment (score <23 on Mini-Mental State Examination)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Brief Behavioral Therapy for Insomnia
Treatment will consist of 4 weekly, 1 hour sessions and will be conducted by a trained graduate assistant on an individual basis. Treatment components will include education about aging and sleep. It will also include instruction in techniques designed to: (a) promote good sleep habits, (b) restrict the use of the bed and bedroom to sleep and sleep-conducive activities, (c) modify bed and wake times to better match the participants sleep needs, and (d) promote relaxation. Daily home practice of these techniques will be encouraged. Participants will maintain logs of their home practice sessions and will continue to record their daily sleep habits throughout treatment.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Missouri-Columbia University of Florida

References & Publications (1)

McCrae CS, McGovern R, Lukefahr R, Stripling AM. Research Evaluating Brief Behavioral Sleep Treatments for Rural Elderly (RESTORE): a preliminary examination of effectiveness. Am J Geriatr Psychiatry. 2007 Nov;15(11):979-82. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in diary-assessed total sleep and wake time during sleep from baseline to follow-up Participants will complete a daily sleep dairies throughout the study period. They will report their bedtime, waketime, sleep onset latency, and wake time after sleep onset. Total sleep time and total wake time will be calculated from the diaries. from baseline to follow-up, approximately 1 year No
Secondary Change in actigraphy-assessed sleep variability from baseline to follow-up Participants wore an Actiwatch-L (ACTL) (Mini Mitter Co., Inc.) on their non-dominant wrists continuously throughout the study. The sensor of the ACTL is sampled 32 times per second and records peak values for each second. These peak values are then summed into 30-second "activity" counts. These activity counts are downloaded to a personal computer and analyzed using Actiware-Sleep v. 3.3, which uses a validated algorithm to identify periods of as sleep or wake. Total sleep time and total wake time will be computed. from baseline to follow-up, approximately 1 year No
Secondary Change in performance on the Mini-Mental Status Exam Mini-Mental Status Exam (MMSE) (Folstein, Folstein, & McHugh, 1975) from baseline to follow-up, approximately 1 year No
Secondary Change in performance on Wechsler Adult Intelligence Scale-3, Vocabulary & Digit Symbol Wechsler Adult Intelligence Scale-3, Vocabulary & Digit Symbol (subtests) [WAIS-3] from baseline to follow-up, approximately 1 year No
Secondary Change in performance on the Trails A & B (Reitan, 1958) Trails A & B (Reitan, 1958) was administered from baseline to follow-up, approximately 1 year No
Secondary Change in performance on the Controlled Oral Word Association Controlled Oral Word Association (COWA) (Benton & Hamsher, 1983) from baseline to follow-up, approximately 1 year No
Secondary Change in performance on the Boston Naming Test (BNT) Boston Naming Test (BNT) from baseline to follow-up, approximately 1 year No
Secondary Change in performance on the California Verbal Learning Test (CVLT, CVLT-II) California Verbal Learning Test (CVLT, CVLT-II) (Delis, Kramer, Kaplan, & Ober, 1987) from baseline to follow-up, approximately 1 year No
Secondary Change in performance on the Rey-Osterreith Complex Figure Test (Rey-O) (Hubley & Tremblay, 2002) from baseline to follow-up, approximately 1 year No
Secondary Change in performance on the Wechsler Memory Scale-3, Logical Memory & Visual Reproduction subtests (WMS-3) Tremblay, 2002) from baseline to follow-up, approximately 1 year No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05561829 - Determination of Optimal Sleep Treatment Elements - MOST N/A
Completed NCT05561790 - Determination of Optimal Sleep Treatment Elements - Pilot N/A
Recruiting NCT06053840 - An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia Phase 4
Terminated NCT04059302 - Internet Cognitive Behavioral Therapy for Insomnia to Prevent Cardiovascular Disease N/A
Recruiting NCT04545606 - Targeting Insomnia in School Aged Children With Autism Spectrum Disorder N/A
Completed NCT04073992 - Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment N/A
Completed NCT03623438 - Self-administered Acupressure for Insomnia Disorder N/A
Completed NCT04565223 - Feasibility and Acceptability of Cognitive Behavioral Therapy for Chronic Insomnia in a Primary Care N/A
Not yet recruiting NCT06351839 - Sleep Well Despite Persistent Pain Symptoms N/A
Completed NCT05078112 - Sleep Device Testing N/A
Active, not recruiting NCT05917379 - The Safety and Efficacy of FMT in Patients With CID Phase 1/Phase 2
Active, not recruiting NCT04627480 - Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial Phase 4
Completed NCT03441191 - Audio-visual Stimulation for Sleep Promotion in Older Adults With Osteoarthritis Pain N/A
Completed NCT04406103 - Protocol - Your Answers When Needing Sleep in New Brunswick N/A
Recruiting NCT05373537 - Treatment to Improve Sleep in Caregivers With Insomnia and a Child With Autism N/A
Recruiting NCT05797324 - Light Therapy in Modulating the Clinical Phenotype of Patients With Primary and Comorbid Chronic Insomnia. N/A
Recruiting NCT06410495 - Digital Dyadic Family Based Intervention to Improve Sleep in Children With ODD and Their Parents: NiteCAPP SINCC (Pilot) N/A
Completed NCT03015766 - Auricular Acupressure for Hemodialysis Patients With Insomnia N/A
Completed NCT03482856 - Cognitive Behavioural Therapy for Insomnia in Chronic Spinal Pain N/A
Completed NCT03569865 - Audio-visual Stimulation: Sleep Dose Response N/A